These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1339181)

  • 21. Immunoexpression of mutant p53 and human papillomavirus related E6 oncoprotein in anal malignancies.
    Gupta S; Sharma BK
    Indian J Exp Biol; 1998 Sep; 36(9):875-8. PubMed ID: 9854426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of human papillomavirus in anogenital cancer.
    Pfister H
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):579-95. PubMed ID: 8869947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual detection of human herpesvirus-6 and human papillomavirus type 16 and 18 in cervical carcinoma.
    Yadav M; Padmanathan A; Arivananthan M
    J Obstet Gynaecol; 1997 Jan; 17(1):86-7. PubMed ID: 15511780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations.
    Szentirmay Z; Pólus K; Tamás L; Szentkuti G; Kurcsics J; Csernák E; Tóth E; Kásler M
    Cancer Metastasis Rev; 2005 Jan; 24(1):19-34. PubMed ID: 15785870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
    Nemes JA; Deli L; Nemes Z; Márton IJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-melanoma skin cancers and human papillomavirus].
    Aubin F; Humbey O; Guérrini JS; Mougin C; Laurent R
    Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1131-8. PubMed ID: 14724516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China.
    Chang F; Syrjänen S; Shen Q; Cintorino M; Santopietro R; Tosi P; Syrjänen K
    Anticancer Res; 2000; 20(5C):3935-40. PubMed ID: 11268480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
    Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF
    Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomaviruses: pediatric perspectives on a family of multifaceted tumorigenic pathogens.
    Cripe TP
    Pediatr Infect Dis J; 1990 Nov; 9(11):836-44. PubMed ID: 2175876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer.
    Palefsky JM; Holly EA; Gonzales J; Berline J; Ahn DK; Greenspan JS
    Cancer Res; 1991 Feb; 51(3):1014-9. PubMed ID: 1846314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
    Heard I; Palefsky JM; Kazatchkine MD
    Antivir Ther; 2004 Feb; 9(1):13-22. PubMed ID: 15040532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV detection rate in saliva may depend on the immune system efficiency.
    Adamopoulou M; Vairaktaris E; Panis V; Nkenke E; Neukam FW; Yapijakis C
    In Vivo; 2008; 22(5):599-602. PubMed ID: 18853753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the humoral immune response to genital papillomaviruses.
    Galloway DA; Jenison SA
    Mol Biol Med; 1990 Feb; 7(1):59-72. PubMed ID: 2157937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Oral and Anogenital Carcinogenesis: Potential Tumorigenic Pathways.
    de Lima MAP; Teodoro IPP; da Silva CGL; Lima MVA
    Crit Rev Oncog; 2019; 24(4):403-413. PubMed ID: 32421994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients.
    Hinten F; Meeuwis KA; van Rossum MM; de Hullu JA
    Crit Rev Oncol Hematol; 2012 Nov; 84(2):161-80. PubMed ID: 22425015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anogenital malignancies and premalignancies: facts and controversies.
    Kutlubay Z; Engin B; Zara T; Tüzün Y
    Clin Dermatol; 2013; 31(4):362-373. PubMed ID: 23806153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and animal studies of the role of viruses in oral carcinogenesis.
    Park NH; Li SL; Xie JF; Cherrick HM
    Eur J Cancer B Oral Oncol; 1992 Oct; 28B(2):145-52. PubMed ID: 1339129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.